[XENE] YoY Quarter Result on 30-Sep-2018 [#Q3]

Stock
[XENE] Xenon Pharmaceuticals Inc.
Announcement Date
06-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- -84.37%
YoY- -85.78%
Quarter Report
XENE's Result
XENE's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
Revenue 8,124 6,554 3,500 0 264 413 4,294 11.20%
PBT -15,650 -9,058 -8,866 -14,383 -7,742 -7,714 -3,827 26.42%
Tax -205 -203 5 678 -902 383 3,007 -
NP -15,445 -8,855 -8,871 -14,383 -7,742 -7,714 -3,827 26.15%
Tax Rate - - - - - - - -
Total Cost 23,569 15,409 12,371 14,383 8,006 8,127 8,121 19.41%
Ratio Analysis
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
NP Margin -190.12 -135.11 -253.46 0.00 -2,932.58 -1,867.80 -89.12 13.44%
Per Share
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
EPS -0.37 -0.25 -0.34 -0.71 -0.43 -0.51 -0.27 5.38%
EPS Diluted -0.37 -0.25 -0.34 -0.71 -0.43 -0.51 -0.27 5.38%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.